Class II HDAC Inhibitors
| Cat. No. | Product Name / Activity |
|---|---|
| 6284 | BRD 73954 |
| Dual histone deacetylase (HDAC) 6/8 inhibitor | |
| 6040 | BRD 9757 |
| Potent and selective HDAC6 inhibitor | |
| 6725 | CHDI 00390576 |
| Potent and selective class IIa HDAC inhibitor; brain penetrant | |
| 4077 | MC 1568 |
| Selective HDAC class IIa inhibitor | |
| 5727 | MC 1742 |
| Potent class I and IIb HDAC inhibitor | |
| 7051 | Tasquinimod |
| High affinity HDAC4 negative allosteric modulator; also binds S100A9; antiangiogenic | |
| 3402 | Tubacin |
| HDAC6 inhibitor; inhibits α-tubulin deacetylation | |
| 6270 | Tubastatin A hydrochloride |
| Potent HDAC6 inhibitor |
Cancer Research Product Guide
Our Cancer Research Guide highlights over 750 products for cancer research.
Request copyRequest PDFEpigenetics Scientific Review
Our Epigenetics review gives an overview of the development of chemical probes for epigenetic targets, and discusses their biological effects.
Request copyRequest PDFCell Cycle Life Science Poster
Our Cell Cycle & DNA Damage Repair poster summarizes the stages of the cell cycle and DNA repair. It also highlights strategies for enhancing replicative stress in cancer cells to force mitotic catastrophe and cell death.
Request copyDownload PDFEpigenetics in Cancer Life Science Poster
Taken from the Cancer Product Guide Edition 3
Our Epigenetics in Cancer poster summarizes the main epigenetic targets in cancer, and highlights chemical compounds for the inhibition of these targets.
Request copyDownload PDFRheumatoid Arthritis Life Science Poster
Written by Adam P. Cribbs et al.
Our Rheumatoid Arthritis poster summarizes the disease pathology and highlights some of the epigenetic modifications associated with the condition.
Request copyDownload PDF